Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuto Shibata

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Geriatrics & Gerontology International|June 6, 2015
Safety and pharmacokinetics of bapineuzumab in a single ascending-dose study in Japanese patients with mild to moderate Alzheimer's diseaseHeii Arai, Kazuo Umemura, Yosuke Ichimiya, et al.
International Journal of Geriatric Psychiatry|July 1, 2022
Development of informant-reported or self-reported MCI-J questionnaireTakashi Asada, Tatsuyuki Kakuma, Miho Ota, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 22, 2013
Genetic association between APOA1 and APOD polymorphisms and Alzheimer's disease in a Japanese populationNobuto Shibata, Tomoyuki Nagata, Shunichiro Shinagawa, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 16, 2015
Associations of common copy number variants in glutathione S-transferase mu 1 and D-dopachrome tautomerase-like protein genes with risk of schizophrenia in a Japanese populationToru Nakamura, Tohru Ohnuma, Ryo Hanzawa, et al.
Plos One|January 8, 2016
Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive ImpairmentNobuyuki Kobayashi, Shunichiro Shinagawa, Tomoyuki Nagata, et al.
International Journal of Psychiatry in Medicine|January 30, 2013
No correlation between plasma NMDA-related glutamatergic amino acid levels and cognitive function in medicated patients with schizophreniaTohru Ohnuma, Yoshie Sakai, Hitoshi Maeshima, et al.
Plos One|December 20, 2016
Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive ImpairmentNobuyuki Kobayashi, Shunichiro Shinagawa, Tomoyuki Nagata, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|September 5, 2014
Safety and tolerability of immune globulin intravenous (human), 10% solution in Japanese subjects with mild to moderate Alzheimer's diseaseHeii Arai, Yosuke Ichimiya, Nobuto Shibata, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 6, 2011
No genetic association between SLC7A10 and Japanese patients with schizophreniaYuto Takebayashi, Tohru Ohnuma, Ryo Hanzawa, et al.
Psychiatric Genetics|March 16, 2006
Genetic association between Notch4 polymorphisms and Japanese schizophrenicsNobuto Shibata, Tohru Ohnuma, Shinji Higashi, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Geriatrics & Gerontology International|June 6, 2015
Safety and pharmacokinetics of bapineuzumab in a single ascending-dose study in Japanese patients with mild to moderate Alzheimer's diseaseHeii Arai, Kazuo Umemura, Yosuke Ichimiya, et al.
International Journal of Geriatric Psychiatry|July 1, 2022
Development of informant-reported or self-reported MCI-J questionnaireTakashi Asada, Tatsuyuki Kakuma, Miho Ota, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 22, 2013
Genetic association between APOA1 and APOD polymorphisms and Alzheimer's disease in a Japanese populationNobuto Shibata, Tomoyuki Nagata, Shunichiro Shinagawa, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|July 16, 2015
Associations of common copy number variants in glutathione S-transferase mu 1 and D-dopachrome tautomerase-like protein genes with risk of schizophrenia in a Japanese populationToru Nakamura, Tohru Ohnuma, Ryo Hanzawa, et al.
Plos One|January 8, 2016
Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive ImpairmentNobuyuki Kobayashi, Shunichiro Shinagawa, Tomoyuki Nagata, et al.
International Journal of Psychiatry in Medicine|January 30, 2013
No correlation between plasma NMDA-related glutamatergic amino acid levels and cognitive function in medicated patients with schizophreniaTohru Ohnuma, Yoshie Sakai, Hitoshi Maeshima, et al.
Plos One|December 20, 2016
Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive ImpairmentNobuyuki Kobayashi, Shunichiro Shinagawa, Tomoyuki Nagata, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|September 5, 2014
Safety and tolerability of immune globulin intravenous (human), 10% solution in Japanese subjects with mild to moderate Alzheimer's diseaseHeii Arai, Yosuke Ichimiya, Nobuto Shibata, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 6, 2011
No genetic association between SLC7A10 and Japanese patients with schizophreniaYuto Takebayashi, Tohru Ohnuma, Ryo Hanzawa, et al.
Psychiatric Genetics|March 16, 2006
Genetic association between Notch4 polymorphisms and Japanese schizophrenicsNobuto Shibata, Tohru Ohnuma, Shinji Higashi, et al.
Pageof 9